Ownership history in Walleye Capital LLC Β· 4 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in AVEANNA HEALTHCARE HLDGS INC (AVAH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Walleye Capital LLC underperformed the S&P 500 by β53.8% annually on this AVAH position. Timing score: 33% (1/3 decisions correct). Average cost basis: $10.02. Maximum drawdown during holding period: β63.1%.
β Significantly underperformed the S&P 500 by 53.8% ann.
3 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
1 of 3 add/trim decisions correct
Best entry: $5.42 (2025 Q1) Β· Worst: $12.37 (2021 Q2)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
3 adds Β· 1 trim. Bought during 0 of 1 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.01% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size